Conducting clinical research—data protection implications
Produced in partnership with Francesca Blythe of Sidley Austin and William Long of Sidley Austin
Conducting clinical research—data protection implications

The following Life Sciences practice note Produced in partnership with Francesca Blythe of Sidley Austin and William Long of Sidley Austin provides comprehensive and up to date legal information covering:

  • Conducting clinical research—data protection implications
  • When and why is data protection relevant to clinical research?
  • Territorial scope of the GDPR
  • Personal data, key-coded data and anonymous data
  • Sensitive personal data including health data
  • Responsibility for compliance
  • Controller and processor
  • Transparency
  • Transparency—further processing
  • Transparency—exceptions
  • More...

BREXIT: On 31 January 2020, the UK ceased to be an EU Member State and entered an implementation period, during which it continues to be subject to EU law. During this period, the General Data Protection Regulation applies in the UK and the UK generally continues to be treated as an EU (and EEA) state for many purposes. Any references to EEA or EU states in this Practice Note should therefore be read to also include the UK until the end of the implementation period. As a third country, the UK can no longer participate in the EU’s political institutions, agencies, offices, bodies (except to the limited extent agreed), but it must submit to the continuing jurisdiction of the Court of Justice of the EU during the implementation period. For further guidance on that period, its duration and the data protection laws that are anticipated to apply after the end of it, see Practice Note: Brexit—implications for data protection. For further reading about the impact of Brexit on the Life Sciences, see: Brexit—Life Sciences and News Analysis: Brexit Bulletin—key updates, research tips and resources.

Data, and consequently data protection compliance, is central to conducting clinical research whether in the context of clinical trials, pharmacovigilance activities and/or scientific research more broadly.

As of 25 May 2018, data protection law in the EU is governed by the EU’s

Related documents:

Popular documents